Investor Makes Proposal to Acquire AIkido Pharma for $8.00 Per Share in Cash Proposal for All-Cash Transaction Represents a 31% Premium to AIKI’s Most Recent Closing Price Urges the Board to Immediately Enter into Good Faith Discussions with the Investor and Work to Deliver a...

Significant Investor in AIkido Pharma Urges Board to Commit to Sell Assets and Return Capital to Stockholders The Board and Management Clearly Have Lost the Confidence of Stockholders Concerned that Allowing the Status Quo to Continue Will Result in More Insider Dealing and Destruction of Stockholder Value ...

Significant Investor in AIkido Pharma Issues Open Letter to Board of Directors Continued Destruction of Value and Poor Corporate Governance is Unacceptable Company Needs a Clear Business Plan to Create Stockholder Value and to Establish Accountability to Investors or Company...